Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
About this item
Full title
Author / Creator
Neelapu, Sattva S. , Tummala, Sudhakar , Kebriaei, Partow , Wierda, William , Gutierrez, Cristina , Locke, Frederick L. , Komanduri, Krishna V. , Lin, Yi , Jain, Nitin , Daver, Naval , Westin, Jason , Gulbis, Alison M. , Loghin, Monica E. , de Groot, John F. , Adkins, Sherry , Davis, Suzanne E. , Rezvani, Katayoun , Hwu, Patrick and Shpall, Elizabeth J.
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Key Points
Chimeric antigen receptor (CAR)-T-cell therapy is a promising approach for the treatment of refractory malignancies, but is associated with unique acute toxicities that need specialized monitoring and management
Cytokine-release syndrome (CRS) and CAR-T-cell-related encephalopathy syndrome (CRES) are the most-common toxicities obse...
Alternative Titles
Full title
Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
Authors, Artists and Contributors
Author / Creator
Tummala, Sudhakar
Kebriaei, Partow
Wierda, William
Gutierrez, Cristina
Locke, Frederick L.
Komanduri, Krishna V.
Lin, Yi
Jain, Nitin
Daver, Naval
Westin, Jason
Gulbis, Alison M.
Loghin, Monica E.
de Groot, John F.
Adkins, Sherry
Davis, Suzanne E.
Rezvani, Katayoun
Hwu, Patrick
Shpall, Elizabeth J.
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6733403
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6733403
Other Identifiers
ISSN
1759-4774,1759-4782
E-ISSN
1759-4782
DOI
10.1038/nrclinonc.2017.148
